Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest®) coagulation test

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 4, 2005, Pages 321-332

  Mendelsohn, E E ^a   Solum, N O ^a   Brosstad, Frank ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ca ionophore; Clotting; Microparticles; Phospholipids; PPP; PRP; Reptilase; Thrombin

Indexed keywords

BATROXOBIN; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID REDUCED REAGENT; REAGENT; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CENTRIFUGATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REPTILASE TIME TEST; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

BLOOD COAGULATION; BLOOD PLATELETS; BLOOD PROTEINS; CALCIUM; FACTOR XII; HUMANS; IONOPHORES; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PEPTIDE FRAGMENTS; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; PROTEIN PRECURSORS; PROTHROMBIN; REPRODUCIBILITY OF RESULTS; SOLVENTS; THROMBIN; THROMBIN TIME;

EID: 21344460045     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510510025719     Document Type: Article

References (12)

1. Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein L. Molecular basis of blood coagulation. In: Hematology: basic principles and practice. 2nd ed. New York: Churchill Livingstone; 1995. pp 1566-87.
2. Janson T, Grimmer Ø. Test conditions and sensitivity of the activated partial thromboplastin time (APPT) test "Cephotest". Farmakoterapi 1976;32:36-46.
3. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999;19:284-6.
4. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-32.
5. Bevers EM, Comfurius P, Zwaal RFA. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev 1991;5:146-54.
6. Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J Biol Chem 1997;272:18240-4.
7. Castro HC, Zingali RB, Albuquerque MG, Pujol-Luz M, Rodrigues CR. Snake venom thrombin-like enzymes: from reptilase to now. Cell Mol Life Sci 2004;61:843-56.
8. Feinstein MB, Fraser C. Human platelet secretion and aggregation induced by calcium ionophores. J Gen Physiol 1975;66:561-81.
9. Aronson DL, Stevan L, Ball AP, Franza R Jr, Finlayson JS. Generation of the combined prothrombin activation peptide (F1+2) during clotting of blood and plasma. J Clin Invest 1977;60:1410-8.
10. Hemker HC. Platelet procoagulant activities: the amplification loops between platelets and the plasmatic clotting system. In: Gresele P, Page CP, Fuster V, Vermylen J, editors. Platelets in thrombotic and non-thrombotic disorders. Pathophysiology, pharmacology and therapeutics. UK: Cambridge University Press; 2002. pp 381-92.
11. Dachary-Prigent J, Pasquet JM, Frayssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Biochemistry 1995;34:11625-34.
12. Baglia FA, Walsh PN. Thrombin-mediated feedback activation of Factor XI on the activated platelet surface is preferred over contact activation by Factor XIIa or Factor XIa. J Biol Chem 2000;275:20514-9.